Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model

Background Glucagon-like peptide-1 (GLP-1) analogues regulate glucose homeostasis and have anti-inflammatory properties, but cause gastrointestinal side effects. The fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism that has poor pharmacokinetic properties,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Endocrine Society 2021-02-01
coleção:	Endocrinology and Metabolism
Assuntos:	glucagon-like peptide 1 fibroblast growth factor 21 atherosclerosis diabetes mellitus inflammation
Acesso em linha:	http://www.e-enm.org/upload/pdf/enm-2020-781.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!